Top researcher investigated
a former associate clinical professor at the University of California Irvine (UCI) whose work has been
covered in the Chronicle, is being investigated by the university for numerous ethical violations.
Dr. See, an infectious disease specialist, published a study in the February issue of the Journal
of the American Nutraceutical Association on the use of nutritional supplements and falsely indicated
that it was funded in part by NIH. He also listed his affiliation with UCI, even though the university
has no record of the research and he had left the school five months earlier. He resigned after
it came to light that he had used patients' blood samples for research projects on AIDS and
CFIDS without obtaining their consent or university authorization to do so.
Mannatech, Inc., the
company that makes the supplements, is currently using the study in its marketing efforts. Dr. See has
acknowledged that he has a financial relationship with Mannatech, and has received more than
$100,000 in speaker fees and research grants since 1998. In addition, his wife has been a distributor
for the company since 1997.
According to the Orange County Register, UCI has opened an
investigation and is reviewing all of Dr. See's research to determine whether he has failed to report
financial interest in other companies that have funded his research and misused other researchers' funds.
The university has also ordered him to stop identifying himself as a UCI researcher.
New faces at NIH
National Institute of Allergy
and Infectious Diseases (NIAID) has named Carole Heilman, PhD, acting director of its Division of Microbiology
and Infectious Diseases, which coordinates CFIDS research. She was previously with NIH's Division of AIDS,
where she was instrumental in developing a grants program to speed the pace of discovery and
development of vaccines to prevent HIV infection. In November Dr. Heilman will take over Dr. George
Curlin's responsibilities as co-chair of the Chronic Fatigue Syndrome Coordinating Committee (CFSCC).
addition, Dr. David Morens has taken over re-sponsibility for managing CFS grants at NIAID, a duty formerly
performed by Leigh Sawyer, DMV, and will become the Executive Secretary of the
CFSCC. A medical epidemiologist with a background in infectious diseases, Dr. Morens has a
strong interest in difficult to diagnose conditions.
Association Executive Director Kim Kenney
has met with both of the new appointees to discuss the CFIDS research portfolio as well as ongoing problems
with the CFIDS research program at NIH.
Ampligen meeting postponed
Chronicle reported that a meeting to explore the creation of a CFIDS Ampligen Community Advisory
Board had been scheduled for July 26-29 in Las Vegas. That meeting has been postponed. For updates about
this event, call Trudy Rink at 530/587-6428, or go online at http://www.cfids-cab.org.
Artist with CFIDS featured
The work of
Mary Degen, a photographer from
Minneapolis, Minn., who has CFIDS, will be featured at one of the first national
exhibits to exclusively highlight artists with disabilities. The show, "Through
the Looking Glass: Fresh Perspectives by Artists with Disabilities" will run
from August 5-September 29, 1999, at the International Photography Hall of Fame
and Museum in Oklahoma. Degen uses lighting and shadows to create images that
represent the steps and stages of healing.
for those who are having trouble getting adequate pain management. State legislatures have begun passing
laws that will shield doctors from prosecution for prescribing narcotics and other medications to treat
Also helping fuel the movement is the fact that The Joint Commission on Accreditation of
Healthcare Organizations recently adopted standards under which hospitals, nursing homes and home care
agencies must "recognize the right of patients to appropriate assessment and management of pain." Nineteen
states now have laws in place to protect doctors who technically "overprescribe" painkillers, as long
as the dose is medically necessary.